Evidence map›Paper›PMID 35385827›Full record

Trial reportThe American journal of tropical medicine and hygiene2022

Prevention of Typhoid Fever by Existing Improvements in Household Water, Sanitation, and Hygiene, and the Use of the Vi Polysaccharide Typhoid Vaccine in Poor Urban Slums: Results from a Cluster-Randomized Trial.

Justin Im, Farhana Khanam, Faisal Ahmmed, Deok Ryun Kim, Sophie Kang, Birkneh Tilahun Tadesse, Fahima Chowdhury, Tasnuva Ahmed, Asma Binte Aziz, Masuma Hoque and 12 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of tropical medicine and hygiene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Risk Factors for Typhoid Fever: Systematic Review.JMIR public health and surveillance · 2025
    Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 6 countries.

Justin ImInternational Vaccine Institute, Seoul, Republic of Korea.
Farhana Khanam
Faisal AhmmedInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Deok Ryun KimInternational Vaccine Institute, Seoul, Republic of Korea.
Sophie KangInternational Vaccine Institute, Seoul, Republic of Korea.
Birkneh Tilahun TadesseInternational Vaccine Institute, Seoul, Republic of Korea.
Fahima ChowdhuryInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Tasnuva AhmedInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Asma Binte AzizInternational Vaccine Institute, Seoul, Republic of Korea.
Masuma HoqueInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Md Taufiqul IslamInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Juyeon ParkInternational Vaccine Institute, Seoul, Republic of Korea.
Xinxue LiuOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Dipika SurNational Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India.
Gideok PakInternational Vaccine Institute, Seoul, Republic of Korea.
Hyon Jin JeonInternational Vaccine Institute, Seoul, Republic of Korea.
Khalequ ZamanInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Ashraful Islam KhanInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Firdausi QadriInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Florian MarksInternational Vaccine Institute, Seoul, Republic of Korea.
Jerome H KimInternational Vaccine Institute, Seoul, Republic of Korea.
John D ClemensInternational Vaccine Institute, Seoul, Republic of Korea.
International Vaccine Institute · KRInternational Centre for Diarrhoeal Disease Research · BDNational Institute of Cholera and Enteric Diseases · INUniversity of Antananarivo · MGUniversity of Cambridge · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modest improvements in household water, sanitation, and hygiene (WASH) and typhoid vaccination can reduce typhoid risk in endemic settings. However, empiric evaluation of their combined impact is lacking. A total of 62,756 persons residing in 80 clusters in a Kolkata slum were allocated randomly 1:1 to either the typhoid Vi polysaccharide (ViPS) vaccine or hepatitis A (Hep A) vaccine. Surveillance was conducted for 2 years before and 2 years after vaccination. We classified households as having "better" or "not better" WASH, and calculated the prevalence of better WASH households in clusters using previously validated criteria. We evaluated the protection by better household WASH, better household WASH prevalence, and ViPS vaccination against typhoid in all cluster members present at baseline using Cox proportional hazard models. Overall, ViPS vaccination was associated with a 55% (P < 0.001; 95% CI, 35-69) reduction of typhoid risk and was similar regardless of better WASH in the residence. Living in a better WASH household was associated with a typhoid risk reduction of 31% (P = 0.16; 95% CI, -16 to 59) overall. The reduction was 48% (P = 0.05; 95% CI, -1 to 73) in Hep A clusters, 6% (P = 0.85; 95% CI, -82 to 51) in ViPS clusters, and 57% (P < 0.05; 95% CI, 15-78) in the population during the 2 years preceding the trial. These findings demonstrate a preventive association of better household WASH in the non-ViPS population, but, unexpectedly, an absence of additional protection from ViPS by better WASH in the ViPS population. This analysis highlights the importance of assessing the combination of WASH in conjunction with typhoid vaccines, and has implications for the evaluation of new-generation typhoid conjugate vaccines.

Indexed as

Typhoid FeverTyphoid-Paratyphoid VaccinesDietary CarbohydratesHumansHygienePoverty AreasSanitationWaterDietary CarbohydratesTyphoid-Paratyphoid VaccinesWater

Identifiers

PMID35385827
PMCPMC8991341
OpenAlexW4221049113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.